CVRx (CVRX) Competitors $8.16 -0.08 (-1.02%) As of 11:08 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. AXGN, SIBN, BVS, AVNS, ZIMV, KIDS, TMCI, CBLL, SMLR, and DCTHShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include AxoGen (AXGN), SiBone (SIBN), Bioventus (BVS), AVANOS MEDICAL (AVNS), ZimVie (ZIMV), OrthoPediatrics (KIDS), Treace Medical Concepts (TMCI), CeriBell (CBLL), Semler Scientific (SMLR), and Delcath Systems (DCTH). These companies are all part of the "medical equipment" industry. CVRx vs. Its Competitors AxoGen SiBone Bioventus AVANOS MEDICAL ZimVie OrthoPediatrics Treace Medical Concepts CeriBell Semler Scientific Delcath Systems CVRx (NASDAQ:CVRX) and AxoGen (NASDAQ:AXGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, earnings, media sentiment, profitability, valuation and dividends. Does the media favor CVRX or AXGN? In the previous week, AxoGen had 6 more articles in the media than CVRx. MarketBeat recorded 9 mentions for AxoGen and 3 mentions for CVRx. CVRx's average media sentiment score of 1.76 beat AxoGen's score of 1.26 indicating that CVRx is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CVRx 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive AxoGen 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more volatility & risk, CVRX or AXGN? CVRx has a beta of 1.26, suggesting that its share price is 26% more volatile than the S&P 500. Comparatively, AxoGen has a beta of 1.03, suggesting that its share price is 3% more volatile than the S&P 500. Which has preferable earnings & valuation, CVRX or AXGN? AxoGen has higher revenue and earnings than CVRx. AxoGen is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCVRx$51.29M4.16-$59.97M-$2.10-3.88AxoGen$187.34M4.07-$9.96M-$0.10-165.70 Is CVRX or AXGN more profitable? AxoGen has a net margin of -2.29% compared to CVRx's net margin of -95.61%. AxoGen's return on equity of -4.43% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets CVRx-95.61% -79.31% -40.96% AxoGen -2.29%-4.43%-2.34% Do analysts prefer CVRX or AXGN? CVRx currently has a consensus target price of $14.00, suggesting a potential upside of 71.65%. AxoGen has a consensus target price of $26.00, suggesting a potential upside of 56.91%. Given CVRx's higher possible upside, analysts clearly believe CVRx is more favorable than AxoGen.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CVRx 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 2.86AxoGen 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do insiders and institutionals hold more shares of CVRX or AXGN? 75.3% of CVRx shares are owned by institutional investors. Comparatively, 80.3% of AxoGen shares are owned by institutional investors. 13.9% of CVRx shares are owned by company insiders. Comparatively, 2.8% of AxoGen shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. SummaryAxoGen beats CVRx on 9 of the 17 factors compared between the two stocks. Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CVRX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$213.52M$6.74B$5.80B$10.16BDividend YieldN/A1.23%5.69%4.61%P/E Ratio-3.8926.1974.7325.99Price / Sales4.1663.51470.3491.76Price / CashN/A21.6337.0859.91Price / Book2.785.0312.256.31Net Income-$59.97M$176.38M$3.28B$270.66M7 Day Performance4.30%1.59%1.39%3.52%1 Month Performance8.60%3.85%7.70%6.79%1 Year Performance7.17%12.98%64.01%28.29% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.7831 of 5 stars$8.16-1.0%$14.00+71.7%+1.6%$213.52M$51.29M-3.89160Positive NewsAXGNAxoGen2.9081 of 5 stars$16.04+0.4%$26.00+62.1%+26.5%$735.28M$187.34M-160.38450Positive NewsSIBNSiBone3.8031 of 5 stars$16.13-1.0%$23.67+46.7%+8.2%$702.77M$167.18M-28.80350Positive NewsBVSBioventus3.3315 of 5 stars$7.21+0.3%$13.75+90.7%-30.9%$596.12M$564.14M-11.821,200Positive NewsAVNSAVANOS MEDICAL2.1473 of 5 stars$12.41-2.5%N/A-47.3%$590.24M$687.80M-1.232,227Positive NewsZIMVZimVie1.2947 of 5 stars$18.89+0.2%$17.75-6.0%+16.6%$531.77M$449.75M-26.991,770News CoveragePositive NewsKIDSOrthoPediatrics4.375 of 5 stars$20.91flat$34.14+63.3%-34.8%$524.29M$204.73M-11.68200Positive NewsTMCITreace Medical Concepts2.5559 of 5 stars$7.11-0.8%$9.83+38.3%+43.9%$452.95M$209.36M-9.00250Positive NewsCBLLCeriBell2.5412 of 5 stars$12.06+2.2%$32.14+166.5%N/A$432.64M$65.44M-4.03N/ASMLRSemler Scientific3.0154 of 5 stars$28.29+0.6%$81.75+189.0%+20.2%$416.31M$56.29M11.64120DCTHDelcath Systems3.1576 of 5 stars$11.55-0.9%$24.50+112.1%+11.7%$407.53M$37.21M231.0060Positive News Related Companies and Tools Related Companies AXGN Competitors SIBN Competitors BVS Competitors AVNS Competitors ZIMV Competitors KIDS Competitors TMCI Competitors CBLL Competitors SMLR Competitors DCTH Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAlert: Prepare for Trump's Dollar OverhaulPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
